Gary Kupfer, MD

Professor of Pediatrics (Hematology / Oncology) and of Pathology; Clinical Program Leader, Pediatric Hematology & Oncology Program, Smilow Cancer Hospital; Section Chief, Pediatric Hematology/Oncology; Clinical Research Program Leader, Pediatric Hematology & Oncology Program, Yale Cancer Center

Departments & Organizations

Cancer Center, Yale: Pediatric Hematology & Oncology Program | Radiobiology & Radiotherapy

Cancer Genetics

Molecular Virology: Virology laboratories

Office of Student Research


Pediatrics: Kupfer Lab | Pediatric Hematology & Oncology

Stem Cell Center, Yale: Stem Cell Self-Renewal and Cell Symmetry

Yale Center of Excellence in Hematology (YCEH)

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development: Genetics and Genomics; Human Disease; Oncogenes, Tumor Suppressor Genes, and Cell Cycle Control | Molecular Medicine, Pharmacology, and Physiology: Cancer Biology and Therapeutics; Genetics, Genomics and Proteomics; Hematology, Vascular Biology and Inflammation; Human Disease Pathology, Physiology and Intervention

Yale Medical Group


The Kupfer laboratory is working on HTLV I Tax protein, which has a unique kinase activation activity. They are harnessing this activity in order to chemosensitize p53 mutant tumor cells, thereby serving as an adjunct to enhance cancer therapy.<_o3a_p>

Education & Training

MD Johns Hopkins University School of Medicine (1989)
BS University of Florida (1983)
Post-doctoral Fellow Dana-Farber Cancer Institute, Boston, MA
Fellow Children's Hospital, Boston, MA
Resident Children's Hospital of Philadelphia, Philadelphia, PA
Research Associate John Hopkins School of Medicine Baltimore, MD
Board Certification AB of Pediatrics, Pediatric Hematology-Oncology (1996)

Honors & Recognition

  • Commonwealth Health Research Board grant awardee (2005)

  • NIH K02 career development award (2002)

  • Concern Foundation Cancer Research Award (2000)

Edit this profile